Christopher Robinson is an associate in Morrison & Foerster’s Intellectual Property Group, focusing on patent litigation (including Hatch-Waxman litigation), as well as trademark, trade secret, and contract litigation.
Mr. Robinson has represented clients from a broad range of technical disciplines, including medical devices, pharmaceutical compounds, medical robotics, consumer electronics, smartphones, and computer software. He has substantial experience in all stages of the litigation process, including pleadings, motion practice, electronic discovery, preliminary injunctions, summary judgment motions, and trial. Prior to attending law school, Mr. Robinson worked as a research assistant for MedImmune Vaccines, using recombinant DNA technology to design live-virus vaccines.
Mr. Robinson received a B.A. in biology from Reed College in 2002, specializing in molecular biology and recombinant DNA technology. He received a J.D. cum laude from Santa Clara University in 2008, where he was named to the Order of the Coif. While in law school, Mr. Robinson served as a judicial extern to the Hon. James Ware of the United States District Court for the Northern District of California. He also participated in the Giles Rich Moot Court Competition, winning an award for Best Appellant Brief.
Smartphone Litigation(Northern District of California). Member of team that successfully tried a high-profile smartphone case leading to a jury verdict of more than $1 billion.
Terumo Corp. v. Lepu Medical Technology (Beijing) Co. et al.(District of New Jersey). Represented medical device manufacturer Terumo in patent infringement lawsuit against competitor Vascular Solutions, resulting in a favorable settlement on the eve of our client’s preliminary injunction hearing.
Source Vagabond Systems Ltd. v. Hydrapak, Inc.(Southern District of New York). Defended hydration backpack manufacturer Hydrapak against patent infringement lawsuit brought by competitor Source Vagabond. Secured early dismissal of action on summary judgment and an award of attorneys’ fees.
The Medicines Company v. APP Pharmaceuticals LLC et al.(District of Delaware). Defended generic drug manufacturer APP Pharmaceuticals in a Hatch-Waxman suit brought by The Medicines Company relating to generic Angiomax® (bivalirudin for injection). The case settled favorably.
Hansen Medical Inc. v. Luna Innovations Inc.(California Superior Court). Represented medical device manufacturer Hansen Medical in trade secret litigation relating to a proprietary medical robotics invention. Prevailed at jury trial resulting in a $36 million verdict.
©1996-2018 Morrison & Foerster LLP. All rights reserved.